| 2026-02-25 | +25.0% | earnings | Seeking Alpha | LeMaitre Vascular GAAP EPS of $0.68 beats by $0.02, revenue of $64.45M beats by $1.63M |
| 2026-02-25 | +25.0% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2026-02-25 | +25.0% | earnings | Yahoo Finance | LeMaitre (NASDAQ:LMAT) Surprises With Q4 CY2025 Sales, Stock Soars - Yahoo Finance |
| 2026-02-25 | +25.0% | earnings | Finviz | LeMaitre (NASDAQ:LMAT) Surprises With Q4 CY2025 Sales, Stock Soars - Finviz |
| 2026-02-25 | +25.0% | earnings | TradingView | LeMaitre (NASDAQ:LMAT) Surprises With Q4 CY2025 Sales, Stock Soars - TradingView |
| 2022-10-27 | -21.5% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2026-02-26 | +19.4% | earnings | Seeking Alpha | LeMaitre projects $280M revenue and $2.91 EPS for 2026 with 12% organic sales growth, driven by international expansion and Artegraft |
| 2026-02-26 | +19.4% | earnings | Seeking Alpha | LeMaitre Vascular, Inc. (LMAT) Q4 2025 Earnings Call Transcript |
| 2026-02-26 | +19.4% | news | Seeking Alpha | LeMaitre Vascular raises dividend by 25% to $0.25 |
| 2026-02-26 | +19.4% | news | Yahoo Finance | LeMaitre (LMAT) Stock Trades Up, Here Is Why - Yahoo Finance |
| 2026-02-26 | +19.4% | news | TipRanks | Lemaitre Vascular Stock Slumps Despite Growth Outlook - TipRanks |
| 2026-02-26 | +19.4% | earnings | StocksToTrade | LeMaitre Sees Growth Surge with Promising Earnings, Revenue Outlook - StocksToTrade |
| 2023-05-02 | +17.2% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2025-05-01 | -15.5% | news | Seeking Alpha | LeMaitre Vascular declares $0.20 dividend |
| 2025-05-01 | -15.5% | earnings | Seeking Alpha | LeMaitre Vascular GAAP EPS of $0.48 misses by $0.02, revenue of $59.9M |
| 2025-05-01 | -15.5% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2024-02-27 | +15.2% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2025-05-02 | -11.8% | earnings | Seeking Alpha | LeMaitre raises 2025 sales guidance to $245M amid strong Q1 growth and international expansion |
| 2025-05-02 | -11.8% | earnings | Seeking Alpha | LeMaitre Vascular, Inc. (LMAT) Q1 2025 Earnings Call Transcript |
| 2025-02-27 | -10.8% | earnings | Seeking Alpha | LeMaitre Vascular GAAP EPS of $0.49 in-line, revenue of $55.72M misses by $0.27M |
| 2025-02-27 | -10.8% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2025-08-05 | +10.3% | earnings | Seeking Alpha | LeMaitre Vascular GAAP EPS of $0.60 beats by $0.03, revenue of $64.2M beats by $1.68M |
| 2025-08-05 | +10.3% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2021-07-13 | -9.6% | legal | SEC EDGAR | LMAT 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-08-06 | +9.4% | news | Seeking Alpha | LeMaitre Vascular declares $0.20 dividend |
| 2025-08-06 | +9.4% | earnings | Seeking Alpha | LeMaitre raises 2025 revenue guidance to $251M with 15% organic growth as international launches accelerate |
| 2025-08-06 | +9.4% | earnings | Seeking Alpha | LeMaitre Vascular, Inc. (LMAT) Q2 2025 Earnings Call Transcript |
| 2024-05-02 | +9.0% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2024-10-31 | +8.1% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2025-02-28 | -7.5% | news | Seeking Alpha | LeMaitre cut to perform by Oppenheimer on valuation |
| 2025-02-28 | -7.5% | news | Seeking Alpha | LeMaitre Vascular raises dividend by 25% to $0.20 per share |
| 2025-02-28 | -7.5% | earnings | Seeking Alpha | LeMaitre Vascular, Inc. (LMAT) Q4 2024 Earnings Call Transcript |
| 2023-11-01 | -7.0% | legal | SEC EDGAR | LMAT 8-K: 1.01, 2.02 (SEC Filing) |
| 2023-02-23 | +6.7% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2021-10-28 | -6.4% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2026-04-15 | -5.9% | executive | Quiver Quantitative | LEMAITRE VASCULAR INC ($LMAT) CEO 2025 Pay Revealed - Quiver Quantitative |
| 2026-04-15 | -5.9% | earnings | MarketBeat | Annex Advisory Services LLC Acquires 13,692 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat |
| 2026-04-15 | -5.9% | earnings | MarketBeat | LeMaitre Vascular (NASDAQ:LMAT) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat |
| 2026-02-27 | -5.1% | earnings | Seeking Alpha | LeMaitre Vascular: The Compounder Keeps Compounding |
| 2026-02-27 | -5.1% | earnings | TIKR.com | LeMaitre Vascular Stock Surges 24% After Q4 Sales Beat. Is the $104 Street Target Still in Play? - TIKR.com |
| 2026-02-27 | -5.1% | earnings | Seeking Alpha | LeMaitre Vascular: The Compounder Keeps Compounding (NYSE:MDT) - Seeking Alpha |
| 2026-02-27 | -5.1% | news | Stock Titan | Five investor conferences spotlight LeMaitre in busy March - Stock Titan |
| 2026-02-27 | -5.1% | news | Stock Titan | LMAT: Morgan Stanley Smith Barney files Form 144 for vested restricted shares (LMAT) - Stock Titan |
| 2025-08-04 | +4.6% | earnings | Seeking Alpha | LeMaitre Vascular Q2 2025 Earnings Preview |
| 2025-08-04 | +4.6% | earnings | Yahoo Finance | LeMaitre Vascular Inc (LMAT) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance |
| 2023-08-01 | +4.0% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2021-09-01 | +3.5% | legal | SEC EDGAR | LMAT 8-K: 1.01, 8.01 (SEC Filing) |
| 2025-04-30 | -3.3% | earnings | Seeking Alpha | LeMaitre Vascular Q1 2025 Earnings Preview |
| 2026-02-06 | -2.9% | news | simplywall.st | Here's Why LeMaitre Vascular (NASDAQ:LMAT) Has Caught The Eye Of Investors - simplywall.st |
| 2025-07-18 | -2.9% | news | simplywall.st | Is LeMaitre Vascular (NASDAQ:LMAT) A Risky Investment? - simplywall.st |
| 2026-03-05 | +2.8% | news | TIKR.com | LeMaitre Vascular Stock: Why Wall Street Sees $109 Mean Target - TIKR.com |
| 2021-04-29 | -2.8% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2022-02-24 | +2.5% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2025-02-26 | -2.4% | earnings | Seeking Alpha | LeMaitre Vascular Q4 2024 Earnings Preview |
| 2021-07-16 | +2.4% | legal | SEC EDGAR | LMAT 8-K: 1.01 and (SEC Filing) |
| 2026-04-14 | -2.3% | earnings | GlobeNewswire | LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026 |
| 2026-04-14 | -2.3% | legal | SEC EDGAR | LMAT 8-K: 5.02 and 8.01 (SEC Filing) |
| 2026-04-14 | -2.3% | earnings | Stock Titan | LeMaitre will post Q1 results after close, then hold a 5 p.m. call - Stock Titan |
| 2026-04-14 | -2.3% | earnings | MarketBeat | LeMaitre Vascular (NASDAQ:LMAT) Reaches New 1-Year High - What's Next? - MarketBeat |
| 2026-04-14 | -2.3% | news | Stock Titan | Board reshuffle at LeMaitre Vascular (NASDAQ: LMAT) for 2026 vote - Stock Titan |
| 2026-04-14 | -2.3% | news | Quiver Quantitative | LMAT | LeMaitre Vascular, Inc. Financials - Income Statement - Quiver Quantitative |
| 2024-06-03 | -2.0% | legal | SEC EDGAR | LMAT 8-K: 5.02, 5.07 (SEC Filing) |
| 2022-09-23 | +2.0% | legal | SEC EDGAR | LMAT 8-K: 5.02 (SEC Filing) |
| 2022-07-28 | +2.0% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2026-03-31 | -1.9% | earnings | Zacks | Tilray Brands' Q3 Earnings on the Horizon: What's in The Offing? |
| 2024-08-26 | -1.9% | legal | SEC EDGAR | LMAT 8-K: 5.02 (SEC Filing) |
| 2026-04-16 | -1.8% | earnings | StockStory | Surgical Equipment & Consumables - Specialty Stocks Q4 Earnings: LeMaitre (NASDAQ:LMAT) Firing on All Cylinders |
| 2026-04-16 | -1.8% | earnings | Yahoo Finance | Surgical Equipment & Consumables - Specialty Stocks Q4 Earnings: LeMaitre (NASDAQ:LMAT) Firing on All Cylinders - Yahoo Finance |
| 2022-04-28 | -1.6% | legal | SEC EDGAR | LMAT 8-K: 2.02, 2.05 (SEC Filing) |
| 2025-11-06 | +1.6% | earnings | Seeking Alpha | LeMaitre Vascular Non-GAAP EPS of $0.62 beats by $0.06, revenue of $61M misses by $1.17M |
| 2025-11-06 | +1.6% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2022-02-04 | +1.6% | news | GuruFocus | LeMaitre Vascular Inc (LMAT) Stock Price & 30 Year Financial Data - GuruFocus |
| 2025-03-31 | +1.6% | news | StockStory | 2 Reasons to Avoid LMAT and 1 Stock to Buy Instead - StockStory |
| 2026-02-24 | -1.6% | earnings | Seeking Alpha | LeMaitre Vascular Q4 2025 Earnings Preview |
| 2026-02-24 | -1.6% | legal | DirectorsTalk Interviews | LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A 13.45% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews |
| 2025-04-22 | +1.5% | earnings | GuruFocus | LeMaitre (LMAT) Sees 14% Revenue Growth, Yet Stock Declines - GuruFocus |
| 2022-09-24 | +1.5% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for LeMaitre Vascular (LMAT) - Zacks Investment Research |
| 2026-04-09 | +1.5% | news | Cổng thông tin điện tử Tỉnh Sơn La | Can LeMaitre Vascular (LMAT) Stock become a market leader | Price at $112.30, Down 0.10% - Open Stock Picks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-09 | +1.5% | news | Cổng thông tin điện tử tỉnh Lào Cai | Can LeMaitre Vascular (LMAT) Stock become a market leader | Price at $112.30, Down 0.10% - Shared Momentum Picks - Cổng thông tin điện tử tỉnh Lào Cai |
| 2021-08-04 | +1.4% | legal | SEC EDGAR | LMAT 8-K: 8.01 (SEC Filing) |
| 2025-02-13 | +1.4% | executive | Seeking Alpha | LeMaitre Vascular appoints Dorian LeBlanc as CFO |
| 2025-02-13 | +1.4% | legal | SEC EDGAR | LMAT 8-K: 5.02 and (SEC Filing) |
| 2026-04-20 | -1.3% | news | StockStory | 3 Cash-Heavy Stocks Walking a Fine Line |
| 2026-04-20 | -1.3% | legal | Stock Titan | LMAT SEC Filings - Lemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2026-03-10 | -1.3% | news | simplywall.st | Stronger 2025 Results, Higher Dividend and Buyback Might Change The Case For Investing In LeMaitre Vascular (LMAT) - simplywall.st |
| 2025-11-05 | -1.2% | earnings | Seeking Alpha | LeMaitre Vascular Q3 2025 Earnings Preview |
| 2024-12-19 | +1.1% | legal | SEC EDGAR | LMAT 8-K: 1.01, 2.03, 3.02 (SEC Filing) |
| 2026-03-27 | -1.1% | news | The Motley Fool | LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know - The Motley Fool |
| 2026-03-27 | -1.1% | news | Stock Titan | Vanguard disaggregates holdings; LMAT ownership shown as 0% (Vanguard) - Stock Titan |
| 2024-08-01 | +1.1% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2025-04-25 | -1.0% | news | Stock Titan | LMAT Stock Price, News & Analysis - Stock Titan |
| 2026-04-08 | -1.0% | earnings | MarketBeat | 69,202 Shares in LeMaitre Vascular, Inc. $LMAT Acquired by Tudor Investment Corp ET AL - MarketBeat |
| 2026-04-08 | -1.0% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is LeMaitre Vascular (LMAT) Stock at a Peak | Price at $113.07, Up 2.48% - Stock Picks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2025-11-07 | +0.9% | earnings | Seeking Alpha | LeMaitre targets 40% Q4 operating income growth and 29% margin as Artegraft expansion accelerates |
| 2025-11-07 | +0.9% | earnings | Seeking Alpha | LeMaitre Vascular, Inc. (LMAT) Q3 2025 Earnings Call Transcript |
| 2025-11-07 | +0.9% | news | Seeking Alpha | LeMaitre Vascular declares $0.20 dividend |
| 2025-01-15 | +0.9% | news | Seeking Alpha | LeMaitre Vascular: Losing Steam |
| 2026-03-01 | -0.8% | earnings | Yahoo Finance | How The LeMaitre Vascular (LMAT) Investment Story Is Evolving With New Targets And Guidance - Yahoo Finance |
| 2025-09-03 | +0.8% | news | StockStory | Why LeMaitre (LMAT) Stock Is Down Today - StockStory |
| 2026-04-19 | +0.8% | news | Simply Wall St. | Is It Too Late To Consider Buying LeMaitre Vascular (LMAT) After Its Strong Share Price Run? |
| 2026-04-19 | +0.8% | news | Yahoo Finance | Is It Too Late To Consider Buying LeMaitre Vascular (LMAT) After Its Strong Share Price Run? - Yahoo Finance |
| 2021-09-14 | +0.6% | news | The Motley Fool | LeMaitre Vascular - LMAT - Stock Price & News - The Motley Fool |
| 2026-03-29 | +0.6% | news | Insider Monkey | Is LeMaitre Vascular, Inc. (LMAT) A Good Stock To Buy Now? |
| 2026-03-29 | +0.6% | news | Yahoo Finance | Is LeMaitre Vascular, Inc. (LMAT) A Good Stock To Buy Now? - Yahoo Finance |
| 2026-03-29 | +0.6% | earnings | MarketBeat | LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat |
| 2026-03-29 | +0.6% | news | Yahoo Finance | Why The LeMaitre Vascular (LMAT) Story Is Evolving As Targets Cluster Around US$111 - Yahoo Finance |
| 2026-03-29 | +0.6% | earnings | MarketBeat | JPMorgan Chase & Co. Has $10.68 Million Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat |
| 2026-03-28 | +0.6% | news | The Motley Fool | A LeMaitre Vascular (LMAT) Insider Sold 2,625 Shares for $285K - The Motley Fool |
| 2026-03-02 | +0.5% | news | Investing.com | Lemaitre Vascular SVP Kamke sells $115k in LMAT stock - Investing.com |
| 2026-03-02 | +0.5% | M&A | Stock Titan | Martha Shadan acquires 477 LeMaitre Vascular (LMAT) shares via PSU - Stock Titan |
| 2026-03-02 | +0.5% | news | Stock Titan | George W. LeMaitre sells 150,000 shares (LMAT) in Form 144 - Stock Titan |
| 2021-07-09 | -0.5% | legal | SEC EDGAR | LMAT 8-K: 5.02 and (SEC Filing) |
| 2023-08-20 | -0.4% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2026-03-21 | +0.4% | news | simplywall.st | Is It Too Late To Consider LeMaitre Vascular (LMAT) After Its Recent Share Price Surge? - simplywall.st |
| 2026-04-07 | +0.4% | news | GlobeNewswire | LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference |
| 2026-04-07 | +0.4% | news | StockStory | 3 Russell 2000 Stocks We Steer Clear Of |
| 2026-04-07 | +0.4% | news | Stock Titan | LeMaitre management to speak at Needham virtual healthcare conference - Stock Titan |
| 2021-07-29 | -0.4% | legal | SEC EDGAR | LMAT 8-K: 2.02 and (SEC Filing) |
| 2025-06-17 | +0.4% | news | Seeking Alpha | LeMaitre Vascular: Scaling Nicely As Global Demand Builds |
| 2025-06-17 | +0.4% | news | Seeking Alpha | LeMaitre Vascular: Scaling Nicely As Global Demand Builds (NASDAQ:LMAT) - Seeking Alpha |
| 2026-04-22 | +0.3% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | LeMaitre Vascular (LMAT) Stock: Market Direction Signals | Q4 2025: EPS Tops Views - EBITDA - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2025-09-15 | -0.2% | news | Seeking Alpha | LeMaitre Vascular: Investment Debate Remains In Place (NASDAQ:LMAT) - Seeking Alpha |
| 2026-04-23 | +0.2% | news | StockStory | 3 Hyped Up Stocks Walking a Fine Line |
| 2026-04-23 | +0.2% | news | Stock Titan | Director at LeMaitre Vascular (LMAT) exercises 2,941 share options - Stock Titan |
| 2026-04-23 | +0.2% | earnings | Xã Thanh Hà | LMAT (LeMaitre Vascular Inc.) posts 13.5% YoY Q4 2025 revenue growth, shares fall 2.75% despite mild EPS beat. - Guidance Downgrade - Xã Thanh Hà |
| 2026-04-23 | +0.2% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | LMAT (LeMaitre Vascular Inc.) posts 13.5% YoY Q4 2025 revenue growth, shares fall 2.75% despite mild EPS beat. - Trending Buy Opportunities - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-23 | +0.2% | earnings | MarketBeat | LeMaitre Vascular (NASDAQ:LMAT) Stock Crosses Above 200 Day Moving Average - Time to Sell? - MarketBeat |
| 2026-04-23 | +0.2% | earnings | MarketBeat | M&T Bank Corp Boosts Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat |
| 2026-04-23 | +0.2% | earnings | MarketBeat | LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat |
| 2026-04-02 | -0.2% | earnings | MarketBeat | SG Americas Securities LLC Raises Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat |
| 2026-04-02 | -0.2% | earnings | MarketBeat | LeMaitre Vascular (NASDAQ:LMAT) Upgraded at Freedom Capital - MarketBeat |
| 2026-03-30 | -0.2% | news | Simply Wall St. | Why The LeMaitre Vascular (LMAT) Story Is Evolving As Targets Cluster Around US$111 |
| 2026-03-30 | -0.2% | news | Stock Titan | [Form 4] LEMAITRE VASCULAR INC Insider Trading Activity - Stock Titan |
| 2026-03-30 | -0.2% | news | Stock Titan | LeMaitre Vascular (LMAT) director granted new dividend equivalent rights - Stock Titan |
| 2026-03-30 | -0.2% | news | Stock Titan | Dividend equivalents boost LeMaitre Vascular (LMAT) director stock awards - Stock Titan |
| 2026-03-30 | -0.2% | news | Stock Titan | LeMaitre (NASDAQ: LMAT) director awarded new dividend equivalent rights - Stock Titan |
| 2026-03-30 | -0.2% | news | Stock Titan | LeMaitre (NASDAQ: LMAT) director receives dividend equivalent rights awards - Stock Titan |
| 2026-03-30 | -0.2% | executive | Stock Titan | LeMaitre Vascular (LMAT) CFO granted new dividend equivalent rights - Stock Titan |
| 2026-03-30 | -0.2% | news | Stock Titan | LeMaitre Vascular (LMAT) president reports grants of dividend equivalent rights - Stock Titan |
| 2026-03-30 | -0.2% | news | Stock Titan | LeMaitre (LMAT) SVP awarded new dividend equivalent rights grants - Stock Titan |
| 2026-03-30 | -0.2% | news | Stock Titan | LeMaitre (NASDAQ: LMAT) director awarded dividend equivalent rights - Stock Titan |
| 2025-10-26 | -0.2% | news | simplywall.st | Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT) - simplywall.st |
| 2024-05-11 | +0.1% | earnings | MarketBeat | LeMaitre Vascular (LMAT) Stock Forecast and Price Target 2026 - MarketBeat |
| 2025-09-16 | -0.0% | news | Seeking Alpha | LeMaitre Vascular: Investment Debate Remains In Place |
| 2026-04-24 | — | earnings | MarketBeat | LeMaitre Vascular, Inc. $LMAT Shares Sold by Copeland Capital Management LLC - MarketBeat |